PER2 and central nervous system cancer: Per2 overexpression could induce glioma stem cell arrest at the G0/G1 phase and suppress glioma proliferation, stemness and invasion ability in vitro and in vivo. Subsequently, the Wnt/β‐catenin signaling pathway was identified as the target of PER2 in glioma stem cells.